- Home
- BGLC vs LDTC Comparison
BGLC vs LDTC Comparison
Compare BGLC & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- LDTC
- Stock Information
- Founded
- BGLC 2017
- LDTC 2007
- Country
- BGLC Malaysia
- LDTC Canada
- Employees
- BGLC N/A
- LDTC N/A
- Industry
- BGLC Medical Specialities
- LDTC Blank Checks
- Sector
- BGLC Health Care
- LDTC Finance
- Exchange
- BGLC Nasdaq
- LDTC Nasdaq
- Market Cap
- BGLC 7.6M
- LDTC 7.9M
- IPO Year
- BGLC N/A
- LDTC N/A
- Fundamental
- Price
- BGLC $0.30
- LDTC $0.31
- Analyst Decision
- BGLC
- LDTC Buy
- Analyst Count
- BGLC 0
- LDTC 3
- Target Price
- BGLC N/A
- LDTC $1.00
- AVG Volume (30 Days)
- BGLC 78.2K
- LDTC 159.5K
- Earning Date
- BGLC 11-20-2024
- LDTC 08-14-2024
- Dividend Yield
- BGLC N/A
- LDTC N/A
- EPS Growth
- BGLC N/A
- LDTC N/A
- EPS
- BGLC N/A
- LDTC N/A
- Revenue
- BGLC $9,183,168.00
- LDTC $6,052,694.00
- Revenue This Year
- BGLC N/A
- LDTC N/A
- Revenue Next Year
- BGLC N/A
- LDTC $2.28
- P/E Ratio
- BGLC N/A
- LDTC N/A
- Revenue Growth
- BGLC N/A
- LDTC 2.76
- 52 Week Low
- BGLC $0.31
- LDTC $0.22
- 52 Week High
- BGLC $3.39
- LDTC $11.20
- Technical
- Relative Strength Index (RSI)
- BGLC 28.91
- LDTC 52.96
- Support Level
- BGLC $0.32
- LDTC $0.28
- Resistance Level
- BGLC $0.38
- LDTC $0.35
- Average True Range (ATR)
- BGLC 0.02
- LDTC 0.04
- MACD
- BGLC -0.00
- LDTC 0.01
- Stochastic Oscillator
- BGLC 0.00
- LDTC 61.24
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation.